NCT01703754 2025-08-28
Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.
Alaunos Therapeutics
Phase 2 Terminated
Alaunos Therapeutics
Indiana University
Alaunos Therapeutics
Alaunos Therapeutics
Alaunos Therapeutics